Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found by following the More Information link in the table below.
|green - headed in the right direction|
|red - headed in the wrong direction|
|black - stable or non-significant change (NSC)|
|purple - indeterminate|
|blue - Healthy People 2030 target|
|Measure Name||HPV Vaccination|
Percentage of adolescents aged 13-15 years who had received 2 or 3 doses of the human papillomavirus (HPV) vaccine as recommended at time of immunization.
From 2008-2011, the recommendation by the CDC’s Advisory Committee on Immunization Practices (ACIP) was for a 3-dose series for females only. From 2011-2016, the recommendation included both males and females using a 3-dose series. Beginning in 2016, ACIP recommended males and females beginning their vaccination series before 15 years of age receive a 2-dose, rather than 3-dose series.
|Recent Summary Trend||Rising|
|Recent Summary Trend Year Range||2016-2020|
|Trends and Most Recent Estimates||In 2020, 54.5% of adolescents aged 13-15 years had received 2+ doses of the HPV vaccine as recommended at time of vaccine.|
|Healthy People 2030 Target||Increase the percentage of adolescents who receive 2 or 3 doses of human papillomavirus (HPV) vaccine as recommended at time of vaccine to 80.00%|
|More Information||HPV Vaccination|
|Last Updated||April 2022|